How I Interpret Clinical Trial Results to Choose Salvage Immunotherapies for Adult Patients With B-Precursor ALL

Discussion - Are you ready to use immunotherapies for your patients with relapsed/refractory ALL? Dan Douer, MD, provides his interpretation of the data and discusses the benefits and risks of different treatments.
Source: Clinical Care Options Leukemia - Category: Hematology Source Type: research